Cal-X Stars Business Accelerator Inc. DBA Leonhardt’s Launchpads Annual Shareholder Meeting Notice May 5th 2017
Second Notice of Annual Shareholders Meeting Cal-X Stars Business Accelerator Inc. a California Corporation
Press Release – Notice is hereby given that the annual general meeting of the shareholders of all classes of stock of Cal-X Stars Business Accelerator Inc. will be held at the company’s headquarters at 2000 Main Street, Santa Monica CA 90405 on Friday May 5th 2017 at 3pm PST for the purpose of:
Here is a link to a table of the Leonhardt Ventures’s Cal-X Stars Business Accelerator Inc. 2016 Portfolio Class of 26 Regenerative Medtech and 4 Regenerative Economy Startups with current valuations and target goals valuations for the end of 2019 – which includes hyperlinks to all the individual startup web sites – http://leonhardtventures.com/our-companies/#toggle-id-1
An advance notice was emailed to all shareholders of record April 5th, 2017 and again on April 19th, 2017 on behalf of the board of directors.
Shareholders not able to attend in person may call into this line at 3pm PST May 5th, 2017 to participate in the meeting.
Cal-X Stars Business Accelerator, Inc. DBA Leonhardt’s Launchpads Board of Directors
Executive Chairman of the Board: Howard J. Leonhardt – eSigned – Howard J. Leonhardt
Secretary & Treasurer: Sofia Yepes
Voting Board Directors: Jeremy Koff, Tricia Nordy, Jeff Donofrio, Dr. Mark Cunningham, Alex Richardson
Committees: Compensation = Chair Jeremy Koff, Ken Evans, Jeff Donofrio
Audit = Brittany Brown CPA, Jeff Donofrio
Legal Counsel = Bruce Methven Corporate Securities, Allen Turner Patents
Board Meeting Attending Non-Voting Advisors (some may attend by Skype): Ken Evans, Paul Norman, Walter Grieves, Laurelle Johnson, Brittany Brown CPA, Bruce Methven Corporate Attorney, Allen Turner Patent Attorney, Kevin Arnal Chief Engineer Biomerics Advanced Catheter, Richard Koffler, Michael Newton, Derek Kahn, Dr. King Liu, Dr. Patrick Johnson, Dr. Santosh Kesari, Tom Newman, Henk Abbink, Joel Hirsch, Dr. Leslie Miller our Chief Medical Officer
Updates will be provided on these portfolio startups and Licensable Technology Platforms (LTPs) including current ownership cap tables and valuation analysis:
Regenerative Medtech Portfolio (26)
*Note – Leonhardt-Wetling JV agreement for wireless microcurrent technology is still pending finalization at time of this notice. If the agreement is not finalized within the next 90 days the board proposes to shareholders adding MucosaCell (sub mucosa regeneration) to the portfolio and dropping Wetling.
Regenerative Economy Portfolio (4)
1. The California Stock Exchange TM – social good stock exchange in development and crowdfunding services – 2011
a. Cal-X Crowdfund Connect – crowdfunding campaign bulding assistance – 2012
b. Cal-X 30 Social Good Impact Fund powered by Motif Investing – 30 curated social good impact stocks – 2015
c. Cal-X Microloans – in collaboration with ZimpleMoney – crowd sourced loans – 2014
d. Cal-X Funders Syndicate -Special Purpose Vehicles and Simple Advance Future Equity Agreements – 2014
e. CalXports – export sales campaign building assistance for California startups – 2013
g. PRETAIL Fashion – pre-selling fashion designs and crowdsourcing most popular designs to go to production – 2015
2. Leonhardt Incubators & Accelerators
a. Cal-X Stars Business Accelerator Inc. – regenerative medtech and economy startup & innovation accelerator – 2013
b. CalXelerator – 108 day startup accelerator/incubator for social good impact companies – 2013
c. SciAccelerator – 108 day startup accelerator for science based tech startups – 2016
d. Leonhardt’s Launchpads NorCal @ University of Northern California Science Technology Innovation Center (UNC STIC) – life science startup incubator – 2007
e. Leonhardt’s Launchpads Utah, Inc. – innovation accelerator focused on organ regneration and recovery – 2015
f. LABioHub – resources for Los Angeles area life science cos. – 2015
g. Startup California – resources for California startups – 2011
3. Kindheart Lionheart Media & Publishing Co. – Social good media- 2006
a. The Kindheart Lionheart TV Network – social good impact online television network – 2014
> California Love TV Program – in house original TV program about new love – 2014
> Love Dialogues TV Program – in house original candid no frills conversations on the topice of love – 2015
> Love Roller Coaster TV Program – original love themed sitcom – 2015
> LIONS DEN Startup Pitch TV Program – in house original online crowdfunding based startup pitch program – 2015
> The Kindheart Lionheart TV and Radio Program – social good profiles of compassion and courage radio and TV show – 2013
b. Kindheart Lionheart Book Club – social good impact book club – 2006
c. Kindheart Lionheart Startup Media Support Services – startup media support including video and animation production – 2014
d. Kindheart Lionheart Adventures – social good charitable vacations and charitable foundation fund raising tools – 2001
e. Radio Veronica USA Radio Santa Monica USA – online radio station that permits listeners to buy into publishing rights of songs – 2010
f. Wine Country Baseball – Sonoma and Napa based summer amateur baseball league to raise funds for local causes and parks – 2009
g. Dolphin Smiles: The Legend of Kindheart Lionheart – (under development with help of UCLA writing program) – in house original story of a person dedicated to social good change reincarnated as a dolphin – 1997
4. Leonhardt Food & Beverage
a. Lucille’s American Cafe’s* (50% worldiwde franchise, trademark and recipes rights) – comfort food restaurants – 1996
b. Food Trikes & Scooters – mini electric food trucks with crowdfunding and micro loans to finance – 2013
c. California Wine Financing – loans to small California family wineries to bridge cash flow gaps – 2008
d. Lionheart Cider* (distribution western states) – Minnesota based cider co. – Leonhardt has option for western states distribution – 2014
e. Leonhardt Oak Aged Beer (development stage) – sour mash beer aged in former oak wine barrels for a unique taste – 2015
Refer to Investor Relations Page for Risks and Warnings Within Our Private Placement Memorandum. Refer to Latest Newsletters for Updates. http://calxstars.com/investor-relations/ and www.leonhardtventures.com
The Cal-X Stars Business Accelerator, Inc. DBA Leonhardt’s Launchpads business model is to accelerate each startup through to first-in-man study results for the regenerative medtech portfolio and through to acquisition of 10,000 customers/subscribers for the regenerative economy startups and then dutch auction them off to the best strategic partner preferrably with 3% royalty on net sales forward.
Securities offered under Rule 506(c) may be purchased only by accredited investors = persons with > 1 million in assets excluding their home and vehicles or whom have income > $200,000 the past two years consecutively or > $300,000 income as a couple. Accreditation status must be verified via documentation of credible third parties in a position to provide accurate verification. Investors in this offering should have experience in making early stage investments.
Cal-X Stars Business Accelerator Inc. develops early stage innovations and startups. By nature the risk is very high for these type of investments. Any investor should be fully prepared without reserve to lose all their investment. Our high focus on developing implantable devices and biologics for treating heart failure add exceptionally higher levels of risk as the products require multiple stages of clinical trials costing many millions of dollars and require high intellectual property protection to succeed commercially. The patent landscape in these areas of participation are wrought with potential for litigation. A high number of clinical trials in the heart failure space fail to prove greater safety and efficacy compared to currently available choices. A high number of early seed stage innovations fail to ever make it to market and even a smaller number become commercial successes. This type of investment is NOT appropriate for nest egg savings.
Accuracy of Information Disclaimer: Representations and warranties – although we fully believe that our executive summaries newsletters websites and other written materials and videos accurately represent a true and accurate general high level picture of our activities history and progress – which is developing about 26 early stage un-proven cardiovascular life innovations and 4 early stage startup social good impact innovations (including new media social good projects) in an accelerator/incubator – we acknowledge that working with a very small core staff covering many thousands of pages of written materials across over 50 web sites with over 4000 sub-pages that we are highly prone to small errors outdated materials and a certain level on inaccuracy and inconsistencies even while fully striving for the utmost accuracy. Across the 30 innovations and over 2000 working partnerships being developed there are changes and events that occur almost daily. We do our best to keep all websites and published materials fully up to date but recognize and make clear it is nearly impossible for our small staff to keep all materials on all web sites 100% up to date despite our best efforts to do so. Investors have the advantage with us that our small staff operates with a very low overhead but the offset disadvantage is that we do not have on hand the staffing to handle all the constant updates and proofreads needed to keep thousands of pages of materials up to date and 100% accurate 100% of the time. If you have ANY direct question about any published item of material interest to you – JUST ASK for clarification by emailing direct Howard Leonhardt at email@example.com or calling our office DIRECT GOOGLE VOICE MAIL LINE at (424) 291-2133. We will strive to provide a clarification or update to you promptly.
Most recent press releases:
Leonhardt’s Launchpads Chooses Biomerics To Provide Contract Manufacturing and Engineering Design Services For Medical Devices
Leonhardt Ventures to Enter Into Worldwide Strategic Collaboration With Neuro Code Tech Holdings for Customized Bioelectric Cancer Treatments
Leonhardt Ventures to Present Heart and Heart Valve Regeneration Technologies at Cardiovascular Research Technologies (CRT) Meeting February 21st in D.C.
Leonhardt’s Launchpads Expands Patent Estate with Option to Exclusive License Agreement With Caltech
Leonhardt and Genovese file Patent for Bioelectric Controlled Expression of PDGF a Powerful Organ Regeneration Cytokine
Pancreacell Presents Updated Design For Total Pancreas Regeneration At Chicago Conference